Vol. 41.Issue. 3. July - September 2024 | Hipertensión y Riesgo Vascular

ISSN: 1889-1837

See more Open Access Option

Indexed in:

Web of Science, Index Medicus/MEDLINE, SCOPUS, IBECS, IME

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

1.2

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

1.7

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.234

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.46

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 41. Issue 3.

Pages 143-206 (July - September 2024)

Editorial

HT and uric acid, uric acid and HT: Is hyperuricemia a new vascular risk factor to consider?

Mencia Benitez Camps

Hipertens Riesgo Vasc. 2024;41:143-4

Originales

Vitamin D3 supplementation in COVID-19 patients with cardiovascular disease and gut dysbiosis

R.L. Sanz, F. García, A. Gutierrez, S. García Menendez, F. Inserra, L. Ferder, W. Manucha

Hipertens Riesgo Vasc. 2024;41:145-53

Assessing levels of uric acid and other cardiovascular markers in prehypertensive and hypertensive adults

L. da Cunha Agostini, L.A. Cota e Souza, N.N.T. Silva, A.C.F. Lopes, L.F. de Medeiros Teixeira, V. de Almeida Belo, W. Coura-Vital, G.N. da Silva, A.A. Lima

Hipertens Riesgo Vasc. 2024;41:154-61